propranolol has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 1 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kriebel, T | 1 |
Korte, T | 1 |
Kandolf, R | 1 |
Jux, C | 1 |
Windhagen-Mahnert, B | 1 |
Bökenkamp, R | 1 |
Bertram, H | 1 |
Paul, T | 1 |
1 other study available for propranolol and Arrhythmogenic Right Ventricular Dysplasia
Article | Year |
---|---|
[Arrhythmogenic right ventricular dysplasia/cardiomyopathy - diagnosis in childhood].
Topics: Adolescent; Adult; Age Factors; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; | 2003 |